Search

Your search keyword '"Hoti, Fabian"' showing total 9 results

Search Constraints

Start Over You searched for: Author "Hoti, Fabian" Remove constraint Author: "Hoti, Fabian" Topic cardiovascular diseases Remove constraint Topic: cardiovascular diseases
9 results on '"Hoti, Fabian"'

Search Results

1. Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.

2. Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.

3. Increased cardiac and stroke death risk in the first year after discontinuation of postmenopausal hormone therapy.

4. Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy.

5. Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality.

6. Empagliflozin Use Is Associated With Lower Risk of All‐Cause Mortality, Hospitalization for Heart Failure, and End‐Stage Renal Disease Compared to DPP‐4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study

7. Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.

8. Vaginal estradiol use and the risk for cardiovascular mortality.

9. Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia.

Catalog

Books, media, physical & digital resources